Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNAs regulating SOX2 in cancer progression and therapy response
Sepideh Mirzaei, Hamidreza Saebfar, Mohammad Gholami, et al.
Expert Reviews in Molecular Medicine (2021) Vol. 23
Closed Access | Times Cited: 20

Showing 20 citing articles:

NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Sepideh Mirzaei, Sam Saghari, Farzaneh Bassiri, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2770-2795
Closed Access | Times Cited: 141
Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: A review
Zhicheng Wei, Jing Chen, Fang Zuo, et al.
Journal of Ethnopharmacology (2022) Vol. 300, pp. 115748-115748
Closed Access | Times Cited: 71
Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy
Milad Ashrafizadeh, Kiavash Hushmandi, Sepideh Mirzaei, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 61
RNA-binding protein SOX2 promotes distal metastasis and cisplatin resistance in non-small cell lung cancer by stabilizing CBLC
Zhiyuan Zhuo, Bo Chen, H. Zhang, et al.
Molecular & Cellular Toxicology (2025)
Closed Access
EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects
Mahshid Deldar Abad Paskeh, Atefeh Mehrabi, Mohammad Gholami, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112532-112532
Open Access | Times Cited: 43
Multifaceted role of NF-κB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, et al.
Environmental Research (2023) Vol. 228, pp. 115767-115767
Closed Access | Times Cited: 15
Plasmonic Biosensors in Cancer-Associated miRNA Detection
Nayoung Kim, Minkun Bae, Euni Cho, et al.
Biosensors (2025) Vol. 15, Iss. 3, pp. 165-165
Open Access
Cervical cancer progression is regulated by SOX transcription factors: Revealing signaling networks and therapeutic strategies
Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Mohammad Gholami, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 144, pp. 112335-112335
Open Access | Times Cited: 33
LncRNA-miRNA interaction is involved in colorectal cancer pathogenesis by modulating diverse signaling pathways
Shadia Hamoud Alshahrani, Zeina S. M. Al-Hadeithi, Sami G. Almalki, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154898-154898
Closed Access | Times Cited: 14
Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
Zhao-Shan Niu, Wenhong Wang, Xiao-Jun Niu
World Journal of Gastroenterology (2022) Vol. 28, Iss. 46, pp. 6433-6477
Open Access | Times Cited: 19
Deregulated transcription factors in the emerging cancer hallmarks
Adria Hasan, Naushad Ahmad Khan, Shahab Uddin, et al.
Seminars in Cancer Biology (2023) Vol. 98, pp. 31-50
Closed Access | Times Cited: 10
Beyond the genome: lncRNAs as regulators of the PI3K/AKT pathway in lung cancer
Waleed Hassan Almalki
Pathology - Research and Practice (2023) Vol. 251, pp. 154852-154852
Closed Access | Times Cited: 9
Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity
Mahmood Khaksary Mahabady, Sepideh Mirzaei, Hamidreza Saebfar, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 5, pp. 2309-2344
Closed Access | Times Cited: 15
Autophagy as a self-digestion signal in human cancers: Regulation by microRNAs in affecting carcinogenesis and therapy response
Mustafa M. Kadhim, Andrés Alexis Ramírez‐Coronel, Abduladheem Turki Jalil, et al.
Pharmacological Research (2023) Vol. 189, pp. 106695-106695
Open Access | Times Cited: 8
Glycolysis in human cancers: Emphasis circRNA/glycolysis axis and nanoparticles in glycolysis regulation in cancer therapy
Ali G. Alkhathami, Ameer S. Sahib, Majed Saad Al Fayi, et al.
Environmental Research (2023) Vol. 234, pp. 116007-116007
Closed Access | Times Cited: 8
Roles of long non-coding RNAs in angiogenesis-related diseases: Focusing on non-neoplastic aspects
Daisong Li, Lili Liu, Xiangqin He, et al.
Life Sciences (2023) Vol. 330, pp. 122006-122006
Closed Access | Times Cited: 7
Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response
Mehrdokht Sadrkhanloo, Maliheh Entezari, Mohsen Rashidi, et al.
European Journal of Pharmacology (2022) Vol. 932, pp. 175212-175212
Closed Access | Times Cited: 10
Crosstalk between Tumor-Associated Macrophages and MicroRNAs: A Key Role in Tumor Microenvironment
Xianghong Zhou, Bo Chen, Zilong Zhang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13258-13258
Open Access | Times Cited: 8
LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression
Tieju Liu, Shihan Liao, Jing Mo, et al.
Journal of Gastroenterology (2022) Vol. 57, Iss. 10, pp. 784-797
Closed Access | Times Cited: 4
Molecular Morbidity Score–Can MicroRNAs Assess the Burden of Disease?
Tom Butler, Matthew G. Davey, Michael J. Kerin
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8042-8042
Open Access
LSD1 is a promising target to treat cancers by modulating cell stemness
Yaoyuan Tong, Xiaoru Wang, Ruonan Li, et al.
Biochemical Pharmacology (2024), pp. 116549-116549
Closed Access
Page 1

Scroll to top